JP Morgan has bagged a trio of life sciences lettings at its Foundation Park scheme in Maidenhead, Berkshire, giving it confidence to push ahead with its next speculative development at the site.
Biogen, Leo Laboratories and LabCorp Clinical Development have each signed a 10-year lease at the park for a combined 56,000 sq ft at the recently constructed Building 5. The companies join Ultra Electronics, which signed a 56,000 sq ft prelet for Building 1 on a 20-year lease in January 2022.
Paul Harris, head of UK real estate asset management at JP Morgan Asset Management, said: “Given current leasing momentum and the park’s diverse tenant mix, we are likely to commence 45,000 sq ft of speculative development with the fully lab-enabled Building 2.”
Bray Fox Smith and Cushman & Wakefield represented JP Morgan.
To send feedback, e-mail tim.burke@eg.co.uk or tweet @_tim_burke or @EGPropertyNews
View top and average rents in Maidenhead >>
